Self-sampling for Non-participants in an Organised Cervical Cancer Screening Programme (CHOiCE)
Status
Conditions
Treatments
Details and patient eligibility
About
The trial will evaluate the effect on participation in organised screening programme of a human papilloma virus (HPV) self-sampling kit directly mailed home or mailed on demand compared with the standard second reminder for regular screening.
Full description
The CHOice trial is a parallel randomised controlled, open label trial. Participants will be equally randomised into three arms: 1) Directly mailed a second reminder including a HPV self-sampling kit; 2) Mailed a second reminder offering a HPV self-sampling kit, to be ordered by e-mail, by text message, by phone, or by website; and 3) Mailed a second reminder for a conventional practitioner-collected sample (control group).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Women resident in the Central Denmark Region who have not participate in cervical cancer screening after an invitation and one reminder
Exclusion criteria
- Women younger than 30 years are not included due to the lower specificity of HPV DNA tests in younger women
Trial design
Primary purpose
Allocation
Interventional model
Masking
9,327 participants in 3 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal